Nonproliferative retinopathy in diabetes type 2. Initial stages and characterization of phenotypes

被引:63
作者
Cunha-Vaz, J
Bernardes, R
机构
[1] AIBILI, Assoc Biomed Res & Innovat Light & Image, Coimbra, Portugal
[2] Univ Hosp Coimbra, Dept Ophthalmol, Fac Med, Ctr Ophthalmol,Inst Biomed Res Light & Image, Coimbra, Portugal
关键词
D O I
10.1016/j.preteyeres.2004.07.004
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
This review addresses the initial stages of nonproliferative diabetic retinopathy in diabetes type 2. The natural history of the initial lesions occurring in the diabetic retina has particular relevance for our understanding and management of diabetic retinal disease, one of the major causes of vision loss in the western world. Diabetic retinal lesions are still reversible at this stage opening entirely new opportunities for effective intervention. Four main alterations characterize these early stages of diabetic retinopathy: microaneurysms/hemorrhages, alteration of the blood-retinal barrier, capillary closure and alterations in the neuronal and glial cells of the retina. These alterations may be monitored by red-dot counting on eye fundus images and by fluorescein leakage and retinal thickness measurements. A combination of these methods through multimodal macula mapping has contributed by identifying three different phenotypes of diabetic retinopathy. They show different types and rates of progression which suggest the involvement of different susceptibility genes. The identification of different phenotypes opens the door for genotype characterization, different management strategies targeted treatments. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:355 / 377
页数:23
相关论文
共 109 条
[91]   UKPDS 50: Risk factors for incidence and progression of retinopathy in Type II diabetes over 6 years from diagnosis [J].
Stratton, IM ;
Kohner, EM ;
Aldington, SJ ;
Turner, RC ;
Holman, RR ;
Manley, SE ;
Matthews, DR .
DIABETOLOGIA, 2001, 44 (02) :156-163
[92]  
SULLIVAN PM, 1990, INVEST OPHTH VIS SCI, V31, P2041
[93]   Imaging visual function with the multifocal m-sequence technique [J].
Sutter, EE .
VISION RESEARCH, 2001, 41 (10-11) :1241-1255
[94]  
Takagi C, 1996, INVEST OPHTH VIS SCI, V37, P2504
[95]  
TORRENTSOLANS T, 2004, INVEST OPHTHALMOL VI, V2985
[96]  
TSO MOM, 1980, ARCH OPHTHALMOL-CHIC, V98, P2032
[97]   Permeability of the blood-retinal barrier in healthy humans - European concerted action on ocular fluorometry [J].
VanSchaik, HJ ;
Heintz, B ;
Larsen, M ;
Leite, E ;
Rosas, V ;
Schalnus, R ;
VanBest, JA .
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 1997, 235 (10) :639-646
[98]   ULTRASTRUCTURAL-LOCALIZATION OF BLOOD RETINAL BARRIER BREAKDOWN IN DIABETIC AND GALACTOSEMIC RATS [J].
VINORES, SA ;
MCGEHEE, R ;
LEE, A ;
GADEGBEKU, C ;
CAMPOCHIARO, PA .
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 1990, 38 (09) :1341-1352
[99]   ELECTRON-MICROSCOPIC IMMUNOCYTOCHEMICAL DEMONSTRATION OF BLOOD-RETINAL BARRIER BREAKDOWN IN HUMAN DIABETICS AND ITS ASSOCIATION WITH ALDOSE REDUCTASE IN RETINAL VASCULAR ENDOTHELIUM AND RETINAL-PIGMENT EPITHELIUM [J].
VINORES, SA ;
VANNIEL, E ;
SWERDLOFF, JL ;
CAMPOCHIARO, PA .
HISTOCHEMICAL JOURNAL, 1993, 25 (09) :648-663
[100]   Familial aggregation of coronary artery calcium in families with type 2 diabetes [J].
Wagenknecht, LE ;
Bowden, DW ;
Carr, JJ ;
Langefeld, CD ;
Freedman, BI ;
Rich, SS .
DIABETES, 2001, 50 (04) :861-866